Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raheleh Roudi

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|January 9, 2019
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies Before and After ChemotherapyGiandomenico Roviello, Silvia Paola Corona, Michele Aieta, et al.
Investigational New Drugs|March 18, 2017
Lung cancer and β-glucans: review of potential therapeutic applicationsRaheleh Roudi, Shahla Roudbar Mohammadi, Maryam Roudbary, et al.
Molecular and Cellular Biochemistry|February 8, 2025
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapyMana Alavi, Raheleh Roudi, Alberto D'Angelo, et al.
Journal of Oncology|July 30, 2019
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than LightsGiandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, et al.
DNA and Cell Biology|December 28, 2023
Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be PhosphorylatedMohammad Rasouli, Fatemeh Safari, Navid Sobhani, et al.
Cancers|October 27, 2022
The Role of Genomics and Proteomics in Lung Cancer Early Detection and TreatmentMohammad Hadi Abbasian, Ali M Ardekani, Navid Sobhani, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2026
The double-edged sword role of tumor-associated macrophages: preventing or causing resistance to immunotherapyRaheleh Roudi, Behnaz Beikzadeh, Babak Beikzadeh, et al.
Pathology, Research and Practice|May 30, 2017
Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinomaMozhdeh Foroozan, Raheleh Roudi, Maryam Abolhasani, et al.
Plos One|July 27, 2018
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patientsZahra Fathi, Seyed Ali Javad Mousavi, Raheleh Roudi, et al.
Journal of Cancer Research and Therapeutics|July 28, 2016
Evaluation of anaplastic lymphoma kinase expression in nonsmall cell lung cancer;a tissue microarray analysisRaheleh Roudi, Gholamreza Haji, Zahra Madjd, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Cancer Biotherapy & Radiopharmaceuticals|January 9, 2019
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies Before and After ChemotherapyGiandomenico Roviello, Silvia Paola Corona, Michele Aieta, et al.
Investigational New Drugs|March 18, 2017
Lung cancer and β-glucans: review of potential therapeutic applicationsRaheleh Roudi, Shahla Roudbar Mohammadi, Maryam Roudbary, et al.
Molecular and Cellular Biochemistry|February 8, 2025
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapyMana Alavi, Raheleh Roudi, Alberto D'Angelo, et al.
Journal of Oncology|July 30, 2019
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than LightsGiandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, et al.
DNA and Cell Biology|December 28, 2023
Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be PhosphorylatedMohammad Rasouli, Fatemeh Safari, Navid Sobhani, et al.
Cancers|October 27, 2022
The Role of Genomics and Proteomics in Lung Cancer Early Detection and TreatmentMohammad Hadi Abbasian, Ali M Ardekani, Navid Sobhani, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2026
The double-edged sword role of tumor-associated macrophages: preventing or causing resistance to immunotherapyRaheleh Roudi, Behnaz Beikzadeh, Babak Beikzadeh, et al.
Pathology, Research and Practice|May 30, 2017
Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinomaMozhdeh Foroozan, Raheleh Roudi, Maryam Abolhasani, et al.
Plos One|July 27, 2018
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patientsZahra Fathi, Seyed Ali Javad Mousavi, Raheleh Roudi, et al.
Journal of Cancer Research and Therapeutics|July 28, 2016
Evaluation of anaplastic lymphoma kinase expression in nonsmall cell lung cancer;a tissue microarray analysisRaheleh Roudi, Gholamreza Haji, Zahra Madjd, et al.
Pageof 7